The Discounted Cash Flow (DCF) valuation of EyeGate Pharmaceuticals Inc (EYEG) is (655.49) USD. With the latest stock price at 35.30 USD, the upside of EyeGate Pharmaceuticals Inc based on DCF is -1957.2%.
Based on the latest price of 35.30 USD and our DCF valuation, EyeGate Pharmaceuticals Inc (EYEG) is a sell. selling EYEG stocks now will result in a potential gain of 1957.2%.
Note: valuation result may not be accurate due to the company's negative earnings.
Range | Selected | |
WACC / Discount Rate | 5.2% - 6.9% | 6.0% |
Long-term Growth Rate | 3.0% - 4.9% | 4.0% |
Fair Price | (5,266.83) - (358.20) | (655.49) |
Upside | -15022.3% - -1114.9% | -1957.2% |